Try
Revolution Medicines Inc.
RVMDUnited States
49 filed reports · 347 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
49 reports · Mar 2020 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 46 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 23 | 46 | Dec 2020 to Sep 2025 |
| Quarterly · 10-QSEC EDGAR | 20 | 3,175 | Mar 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 6 | 2,492 | Dec 2020 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 332 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 182 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 25, 2026 | 738 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 220 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 5, 2025 | 2 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 6, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 6, 2025 | 130 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 7, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 130 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 26, 2025 | 367 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Feb 26, 2025 | 2 | Open |
| FY2024 Q3 | 8-K | Sep 30, 2024 | Nov 6, 2024 | 2 | Open |
Financial data
347 concepts · 5,713 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial342 concepts · 5,629 facts · Dec 2018 to Jul 2026
- Restricted cash48 · Dec 2018 to Jun 2026
- Accrued expenses and other current liabilities43 · Dec 2019 to Jun 2026
- Cash and cash equivalents at carrying value39 · Dec 2018 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents39 · Dec 2018 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations39 · Dec 2018 to Jun 2026
- Stockholders equity (US GAAP)39 · Dec 2018 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value38 · Dec 2018 to Jun 2026
- Allocated share based compensation expense38 · Dec 2018 to Jun 2026
- Amortization of intangible assets38 · Dec 2018 to Jun 2026
- Capital expenditures incurred but not yet paid38 · Dec 2018 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect38 · Dec 2018 to Jun 2026
- Comprehensive income net of tax38 · Dec 2018 to Jun 2026
- General and administrative expense (US GAAP)38 · Dec 2018 to Jun 2026
- Increase decrease in accounts payable38 · Dec 2018 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities38 · Dec 2018 to Jun 2026
- Increase decrease in other noncurrent liabilities38 · Dec 2018 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets38 · Dec 2018 to Jun 2026
- Investment income interest38 · Dec 2018 to Jun 2026
- Net cash provided by used in financing activities38 · Dec 2018 to Jun 2026
- Net cash provided by used in investing activities38 · Dec 2018 to Jun 2026
- Net cash provided by used in operating activities38 · Dec 2018 to Jun 2026
- Net income loss38 · Dec 2018 to Jun 2026
- Nonoperating income expense38 · Dec 2018 to Jun 2026
- Operating expenses (US GAAP)38 · Dec 2018 to Jun 2026
Guidance1 concepts · 46 facts · Mar 2021 to Nov 2025
- Net Income Guidance46 · Mar 2021 to Nov 2025
Product1 concepts · 23 facts · Dec 2018 to Mar 2023
- Revenue23 · Dec 2018 to Mar 2023
Geography3 concepts · 15 facts · Dec 2018 to Jun 2026
- Payments for proceeds from tenant allowance8 · Dec 2024 to Jun 2026
- Federal4 · Dec 2020 to Dec 2021
- Sublease income3 · Dec 2018 to Dec 2020
Segments
38 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service2 members · 23 facts
- Collaboration Revenue22 · Dec 2018 to Mar 2023
- Collaboration Revenues Other1 · Dec 2018
Statement geographical3 members · 15 facts
- Redwood City California11 · Dec 2018 to Jun 2026
- MA2 · Dec 2020 to Dec 2021
- NJ2 · Dec 2020 to Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary121 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary172 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes20 claims from 1 reports · Dec 2025
- Risk factors165 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
- FY2026 Q1May 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.